ACC 2022
David Berg – Assessment of Atherothrombotic Risk in Patients with Type 2 Diabetes Mellitus
Brian Bergmark – TRANSLATE-TIMI 70
Kazuma Oyama – Serial Assessment of Biomarkers and the Risk of Heart Failure in Patients
AHA 2021
Ankeet Bhatt – Multi-Marker Risk Assessment in Patients Hospitalized with COVID-19
ESC 2021
Kazuma Oyama – Acute arterial events across all vascular territories in the FOURIER trial
Nicholas Marston – Cardiovascular Benefit of Lowering LDL-C Below ~1 mmol per L (40 mg per dl)